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Editorial

MiR-29/Hsp47 in ECM network
Ren Xu

Comments on: Chaperone hsp47 drives malignant growth and invasion by modulating an ECM gene network. Cancer Research.
2015, April, 75(8):1580–91

Cancer development and progression require
extensive reorganization of extracellular matrix [1, 2].
ECM is a complex mixture of structural proteins,
glycoproteins, and proteoglycans, which provide not
only essential physical scaffolds to maintain tissues
structure but also various biochemical signals to
modulate cellular function. Altering the fine balance of
ECM signal is sufficient in the long run to induce breast
cancer development and progression. Although ECM
has been identified as a determinant factor in the tumor
microenvironment that controls cancer development and
progression, but how ECM microenvironmental cues
integrate at the genome level to promote breast cancer
progression remains to be determined.
Gene co-expression network analysis is a systems
biology method using correlation statistics as pairwise
similarity measurements between gene expression
profiles to illustrate the strong relationship which
connects transcripts’ regulatory patterns to the functional
organization of the cell [3]. Using gene co-expression
network analysis of more than 700 human breast cancers,
we have showed that ECM microenvironment is regulated
at the transcription network level during breast cancer
development [3]. Importantly, we have identifed Hsp47
as a hub of the ECM transcription network genes in
breast cancer tissue [4]. Hsp47 is a protein chaperon
and facilitates folding and secretion of collagen in the
endoplasmic reticulum. Hsp47 gene locates at 11q13, a
region that is often amplified in cancer tissue. Increased
Hsp47 expression is associated with high cancer stages
and short recurrent-free survival. We demonstrate that
Hsp47 promotes tumor growth and invasion by enhancing
ECM deposition in breast cancer cells [4]. These results
indicate that Hsp47, possibly through its regulation of
ECM network, is crucial for cancer progression and may
represent a potential biomarker and therapeutic target.
Another important finding from the co-expression
network analysis is the negative association between
miR-29b/c levels and the ECM network gene expression
in human breast cancer tissues. MiR-29 has recently
been identified as a tumor suppressor by altering tumor
microenvironment [5]. MiR-29 binding sites are enriched
in the 3′UTR regions of the ECM network genes.
Moreover, introduction of miR-29 mimics significantly
reduces the expression of Hsp47 and other ECM network
www.impactjournals.com/oncoscience

genes [4]. These results suggest that miR-29 is a critical
negative regulator of ECM microenvironment and
represses ECM protein expression at the transcription
network level. Given the therapeutic potential of
microRNA, identifying roles for miR-29 in regulating the
ECM network may lead to discovery of a novel target for
the inhibition of ECM-dependent cancer progression.
Stromal cells have been considered major source of
ECM proteins. However, our and others’ studies demonstrate
that cancer cells are an active and important component in
ECM remodeling, and that this process is required for cancer
progression and metastasis. Cancer cells are an important
source of ECM in cancer tissue and deposit a significant
amount collagen, fibronectin, and tenascin-C [6]. However,
roles of cancer cell–produced ECM in the cancer progression
have not been appreciated until recently. We show that
breast cancer cells express multiple ECM transcription
network genes. Introducing miR-29 or silencing Hsp47
in breast cancer cells suppresses malignant phenotypes in
breast cancer cell lines by reducing collagen and fibronectin
deposition. In addition, silencing Col4A1 or FN1 in breast
cancer cells represses malignant phenotypes in 3D cultures
[4]. These results suggest that cancer cell-deposited ECM
proteins are crucial for cancer progression. Although
cancer cells and stromal cells in breast cancer tissue both
generate significant amount of ECM proteins, the roles
of these proteins in cancer progression may be different.
It has been shown that LAMA4 produced by cancer cells
governs primary and metastatic tumor re-initiation [7]. Our
unpublished data demonstrate cancer cell–produced ECM
proteins enhance dissemination and survival of tumor cells
during the early phases of metastasis. These experiments
provide strong evidence that ECM molecules generated by
cancer cell promote cancer progression through enhancing
cell survival and proliferation as essential components of the
cancer cell niche.
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